Shares of diagnostic chain Dr Lal PathLabs and pharmaceutical firm Alkem Laboratories on Wednesday opened over 30% higher than their respective issue prices, following successful initial public offerings (IPOs) earlier in December. Dr Lal PathLabs has raised ₹638 crore through its IPO which was over-subscribed 33.41 times, while Alkem’s ₹1,350 crore IPO witnessed 44.29 times over-subscription.